GLP-1 and Alcohol: What You Need to Know
GLP-1 medications dramatically change how your body processes alcohol. Most patients experience increased intoxication from smaller amounts, while some lose interest in drinking altogether.
Expert-written guides to help you make informed health and wellness decisions.
273 articles across 13 health topics
GLP-1 medications dramatically change how your body processes alcohol. Most patients experience increased intoxication from smaller amounts, while some lose interest in drinking altogether.
Almost everyone on GLP-1 medication hits a plateau at some point. Weight stops dropping even though you are still taking the medication and following the plan. This is normal, expected, and manageable.
GLP-1 medications offer powerful benefits for women with PCOS beyond weight loss. These treatments address insulin resistance, restore ovulation, and improve fertility outcomes in 60-80% of patients with polycystic ovary syndrome.
In early 2026, deals were announced between the Trump administration and both Eli Lilly and Novo Nordisk to lower GLP-1 drug prices through the TrumpRX program. Here is what actually changed, what is available, and what the limitations are.
Clinical trial data shows clear efficacy differences between GLP-1 medications. Zepbound leads with 22.5% average weight loss, while newer high-dose formulations push results even higher.
The choice between GLP-1 pills and injections comes down to convenience versus effectiveness. Injections deliver superior weight loss results, while pills offer lifestyle flexibility and eliminate needle anxiety.
Wegovy 7.2mg is currently the strongest weight loss medication, delivering 20.7% average weight loss in clinical trials. Zepbound follows closely at 20-22%, while investigational retatrutide shows 24%+ results in Phase 3 trials.
Foundayo is Eli Lilly's once-daily weight loss pill containing orforglipron, a non-peptide GLP-1 receptor agonist. Unlike other oral GLP-1 medications, you can take Foundayo with food and water at any time of day.
The Wegovy pill costs $149 per month through April 15, 2026, as part of Novo Nordisk's launch pricing. After that, the regular price is $199 monthly for the 4mg dose, with higher doses costing more.
GLP-1 medications don't directly cause hair loss, but rapid weight loss can trigger telogen effluvium—temporary hair thinning that affects 10-25% of patients. This usually resolves within 6-12 months with proper support.
Yes, most patients can take GLP-1 medications long term. Obesity is a chronic medical condition requiring ongoing treatment, similar to diabetes or high blood pressure. Clinical studies show continued safety and effectiveness for 5+ years.
Both Wegovy and Ozempic contain semaglutide, but the FDA approved them for different primary uses. This creates confusion about which to request and insurance implications for weight loss treatment.